Correction: Evaluating the predictive effect of vitamin D on clinical outcomes of infliximab-treated Crohn’s disease patients

Correction: Evaluating the predictive effect of vitamin D on clinical outcomes of infliximab-treated Crohn’s disease patients

Saved in:

Bibliographic Details
Main Authors:	Jiao Zheng, Hongping Gao, Yu Zhang, Mingxuan Sun, Hang Sun, Ying Pei
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Immunology
Subjects:	Crohn’s disease vitamin D infliximab remission rate gastroenterology
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1651209/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluating the predictive effect of vitamin D on clinical outcomes of infliximab-treated Crohn’s disease patients
by: Jiao Zheng, et al.
Published: (2025-06-01)

The efficacy of infliximab combined with partial enteral nutrition in the treatment of Crohn’s disease: a cohort study
by: Chen Huang, et al.
Published: (2025-06-01)

Psoas muscle CT radiomics-based machine learning models to predict response to infliximab in patients with Crohn’s disease
by: Zhuoyan Chen, et al.
Published: (2025-12-01)

Development and validation of a nomogram for predicting endoscopic healing in crohn’s disease patients receiving infliximab treatment
by: Lixuan Li, et al.
Published: (2025-07-01)

The role of proactive therapeutic drug monitoring in guiding infliximab therapeutic optimization in pediatric patients with Crohn's disease: A retrospective study
by: Junya Song, et al.
Published: (2024-12-01)

Tracing the historical foundations of infliximab in Crohn’s disease treatment: a cited reference analysis
by: Andy Wai Kan Yeung
Published: (2024-11-01)

Experience with long-term infliximab therapy in patients with ankylosing spondylitis
by: Oksana Alekseevna Rumyantseva, et al.
Published: (2010-12-01)

Effects of infliximab biosimilar on retinal microvasculature in Crohn’s disease patients evaluated by optical coherence tomography angiography
by: Hesham M. El Mazar, et al.
Published: (2025-01-01)

Toll-like Receptor Gene Polymorphisms as Predictive Biomarkers for Response to Infliximab in Japanese Patients with Crohn’s Disease
by: Jingjing Wei, et al.
Published: (2025-04-01)

EFFICACY OFINFLIXIMABIN THE TREATMENTOF CROHN’S DISEASEIN CHILDREN
by: E. G. Tsimbalova, et al.
Published: (2012-01-01)

Case Report: Facial Malassezia folliculitis following infliximab treatment in Crohn’s disease
by: Liji Chen, et al.
Published: (2025-08-01)

Higher induction and maintenance infliximab trough levels are associated with radiological perianal fistula healing in pediatric patients with Crohn's disease
by: Joonhyuk Son, et al.
Published: (2025-05-01)

Clinical usefulness of the Mucosal Inflammation Noninvasive Index in newly diagnosed paediatric Crohn’s disease patients
by: Roma B. Herman, et al.
Published: (2021-10-01)

Biosimilar infliximab versus originator in Crohn’s disease anti-TNF-α naïve and non-naïve patients
by: Magdalena Kaniewska, et al.
Published: (2020-11-01)

Prediction of deep remission through serum TNF-α level at 1 year of treatment in pediatric Crohn’s disease
by: Seon Young Kim, et al.
Published: (2025-04-01)

Switching from intravenous to subcutaneous infliximab in patients with immune mediated diseases in clinical remission
by: Nikos Viazis, et al.
Published: (2025-05-01)

CLINICOPATHOLOGIC PECULIARITIES OF NONSPECIFIC ULCERATIVE COLITIS AND CROHN'S DISEASE
by: S. D. Strelkova, et al.
Published: (2021-07-01)

Comparison of endoscopic healing and durability between combination therapy with infliximab and azathioprine versus infliximab monotherapy in pediatric Crohn’s disease
by: Yoon Zi Kim, et al.
Published: (2025-07-01)

Managing Crohn’s Disease Postoperative Recurrence Beyond Prophylaxis: A Comprehensive Review with Meta-Analysis
by: Andrei Ovidiu Olteanu, et al.
Published: (2024-10-01)

Russian registry of Infliximab.Impact of therapy on the functional status of patients with rheumatoid arthritis
by: V N Amirdzhanova, et al.
Published: (2010-12-01)

Heart failure in paediatric Crohn’s disease patient – extraintestinal manifestation, concomitant disease or iatrogenic effect?
by: Snehil Swaraj, et al.
Published: (2024-12-01)

Clinical Profile of Ankylosing Spondylitis and Outcome of Patients Treated with Infliximab
by: Dipankar Pal, et al.
Published: (2025-04-01)

The simplified GLIM criteria for assessment of malnutrition and its correlation with clinical outcomes in Crohn’s disease patients
by: Xiaomei Song, et al.
Published: (2025-01-01)

INFLIXIMAB: HAVE ALL QUESTIONS BEEN ANSWERED FOR 10 YEARS?
by: R M Balabanova, et al.
Published: (2010-03-01)

An adolescent case of extensive Behçet`s disease successfully treated with Infliximab
by: Emel Isıyel, et al.
Published: (2019-08-01)

Infliximab in the therapy of rheumatoid arthritis
by: G. V. Lukina, et al.
Published: (2016-05-01)

INFLIXIMAB (REMICADE): POSSIBILITIES IN THE TREATMENT OF RHEUMATOID ARTHRITIS
by: Nataliya Vladimirovna Chichasova, et al.
Published: (2011-03-01)

The role of vitamin D deficiency and modifiable risk factors in patients with Crohn’s disease
by: Xiaoyue Feng, et al.
Published: (2025-07-01)

THE EXPERIENCE OF INFLIXIMAB USAGE IN JUVENILE ARTHRITIS IN THE REPUBLIC OF BASHKORTOSTAN
by: V. A. Malievskii, et al.
Published: (2012-11-01)

Comparative efficacy of infliximab and adalimumab in patients with ankylosing spondylitis
by: Tatyana Valentinovna Mezenova, et al.
Published: (2012-04-01)

Predictors of infliximab efficacy in patients with severe attack of ulcerative colitis
by: A. O. Golovenko, et al.
Published: (2013-10-01)

Hemorrhagic gastric ulcer in a patient with Behcet's disease successfully treated with infliximab
by: Shun Fujiwara, et al.
Published: (2023-04-01)

BIOLOGICAL THERAPY IN ADULT PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE: BUDGET IMPACT ANALYSIS
by: E. A. Pyadushkina
Published: (2017-05-01)

Comparative Effectiveness of Risankizumab vs Other Biologics in Crohn’s Disease: Long-Term and Quality-of-Life Outcomes after Inadequate Response to Prior Therapy
by: Monika Babczyńska, et al.
Published: (2025-05-01)

How We Can Personalize the Infliximab Use in Ulcerative Patients
by: Mohammed Hussien Ahmed, et al.
Published: (2025-06-01)

Efficacy and safety probiotics as adjuvant treatment for Crohn's disease: a meta-analysis of randomized controlled trials
by: Qingfan Zheng, et al.
Published: (2025-01-01)

Early versus late initiation of infliximab for refractory uveitis in a cohort of Egyptian BD patients
by: Mariam R Fadel, et al.
Published: (2024-08-01)

Results of non-medical switching from original infliximab to its Russian biosimilar in patients with ulcerative colitis
by: Maria I. Timanovskaia, et al.
Published: (2025-01-01)

Health-related quality of life outcomes among vedolizumab-treated patients with inflammatory bowel disease in the UK and Ireland: a 52-week observational study (OCTAVO)
by: Gareth Parkes, et al.
Published: (2025-07-01)

ATTEMPT OF OVERCOMING SECONDARY INEFFECTIVENESS OF INFLIXIMAB IN A PATIENT WITH ANKYLOSING SPONDYLITIS USING PLASMAPHERESIS (A CASE REPORT)
by: Oksana Alekseyevna Rumyantseva, et al.
Published: (2014-02-01)